Norman E. Sharpless
Impact in
- Aging top 0.05%
- Genetics, Aging, and Longevity in Model Organisms
- Cancer Research top 0.05%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- DNA Repair Mechanisms 13
- Epigenetics and DNA Methylation 13
- RNA modifications and cancer 11
- Melanoma and MAPK Pathways 11
- Oncology 58
- Cancer-related Molecular Pathways 33
- Co-authors
- William R. Jeck (10 shared papers)Ronald A. DePinho (24 shared papers)Shenghui He (6 shared papers)Christin E. Burd (11 shared papers)Janakiraman Krishnamurthy (21 shared papers)Jessica A. Sorrentino (11 shared papers)Kai Wang (1 shared paper)Michael K. Slevin (1 shared paper)
- Journals
- Journal of Clinical Investigation (16 papers)Cancer Research (9 papers)Cell (7 papers)Proceedings of the National Academy of Sciences (6 papers)PLoS ONE (6 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Norman E. Sharpless
195 papers receiving 28.0k citations
Norman E. Sharpless's Hit Papers
Peers
Comparison fields: 5 of 182
- Aging 1.6k
- Cancer Research 7.2k
- Molecular Biology 16.9k
- Physiology 5.7k
- Oncology 5.1k
Countries citing papers authored by Norman E. Sharpless
This map shows the geographic impact of Norman E. Sharpless's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman E. Sharpless with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman E. Sharpless more than expected).
Fields of papers citing papers by Norman E. Sharpless
This network shows the impact of papers produced by Norman E. Sharpless. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman E. Sharpless. The network helps show where Norman E. Sharpless may publish in the future.
Co-authors
The 25 scholars most cited alongside Norman E. Sharpless, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 205 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Circular RNAs are abundant, conserved, and associated with ALU repeats Hit paper breakdown → | 2012 | 3472 |
| 2 | Detecting and characterizing circular RNAs Hit paper breakdown → | 2014 | 2096 |
| 3 | Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice Hit paper breakdown → | 2015 | 1344 |
| 4 | Senescence in Health and Disease Hit paper breakdown → | 2017 | 1301 |
| 5 | Ink4a/Arf expression is a biomarker of aging Hit paper breakdown → | 2004 | 1175 |
| 6 | Forging a signature of in vivo senescence Hit paper breakdown → | 2015 | 840 |
| 7 | Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a Hit paper breakdown → | 2006 | 819 |
| 8 | p16INK4a induces an age-dependent decline in islet regenerative potential Hit paper breakdown → | 2006 | 786 |
| 9 | The Regulation of INK4/ARF in Cancer and Aging Hit paper breakdown → | 2006 | 774 |
| 10 | Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing Hit paper breakdown → | 2006 | 735 |
| 11 | Expression of Linear and Novel Circular Forms of an INK4/ARF-Associated Non-Coding RNA Correlates with Atherosclerosis Risk Hit paper breakdown → | 2010 | 728 |
| 12 | Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis Hit paper breakdown → | 2001 | 665 |
| 13 | How stem cells age and why this makes us grow old Hit paper breakdown → | 2007 | 641 |
| 14 | Epidermal growth factor receptor and Ink4a/Arf Hit paper breakdown → | 2002 | 500 |
| 15 | 2006 | 492 | |
| 16 | 1999 | 432 | |
| 17 | 2000 | 407 | |
| 18 | 2012 | 369 | |
| 19 | 2009 | 365 | |
| 20 | 2004 | 358 |
About Norman E. Sharpless
Norman E. Sharpless is a scholar working on Molecular Biology, Oncology, Physiology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 205 papers that have together received 28.3k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (40 papers), Cancer-related Molecular Pathways (33 papers), DNA Repair Mechanisms (13 papers), Epigenetics and DNA Methylation (13 papers), Cancer Genomics and Diagnostics (11 papers), RNA modifications and cancer (11 papers), Melanoma and MAPK Pathways (11 papers) and Genetics, Aging, and Longevity in Model Organisms (11 papers). The work is most often cited by research in Aging (1.6k citations), Cancer Research (7.2k citations), Molecular Biology (16.9k citations), Physiology (5.7k citations) and Oncology (5.1k citations). Norman E. Sharpless has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include William R. Jeck, Ronald A. DePinho, Shenghui He, Christin E. Burd, Janakiraman Krishnamurthy, Jessica A. Sorrentino, Kai Wang, Michael K. Slevin, Jinze Liu and William F. Marzluff. Their work appears in journals such as Journal of Clinical Investigation, Cancer Research, Cell, Proceedings of the National Academy of Sciences and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.